Literature DB >> 26789718

Bundling Human Papillomavirus Vaccination and Rapid Human Immunodeficiency Virus Testing for Young Gay and Bisexual Men.

Jacob J van den Berg1,2, H Elsa Larson3, Gregory D Zimet4, Michelle A Lally1,2,5.   

Abstract

This study explored the feasibility and acceptability of a bundled human papillomavirus (HPV) vaccine and human immunodeficiency virus (HIV) testing program for young gay and bisexual men (YGBM). YGBM aged 18-26 years (N=55) were recruited to receive HPV vaccine with optional HIV testing and personalized counseling. Sexual risk behaviors and knowledge were assessed at three study visits. By visit 3, about 98% had received an HIV test with HPV vaccination; 59% received repeat HIV testing. Findings support the bundling of HPV vaccination with HIV testing among YGBM. Future directions include examining the scalability of integrating clinic-based HIV and HPV healthcare services.

Entities:  

Keywords:  HIV prevention; HIV testing; HPV vaccination; gay/bisexual men; repeat HIV testing; sexual healthcare.

Year:  2014        PMID: 26789718     DOI: 10.1089/lgbt.2014.0028

Source DB:  PubMed          Journal:  LGBT Health        ISSN: 2325-8292            Impact factor:   4.151


  3 in total

1.  An Integrative Theoretical Framework for HPV Vaccine Promotion Among Male Sexual Minorities.

Authors:  Christopher W Wheldon; Ellen M Daley; Eric R Walsh-Buhi; Julie A Baldwin; Alan G Nyitray; Anna R Giuliano
Journal:  Am J Mens Health       Date:  2016-06-06

2.  Promoting vaccination during rapid HIV testing: Recommendations from men who have sex with men in California.

Authors:  Andrea N Polonijo; Shawna Sein; Raul Maldonado; Jorge Delos Santos; Brandon Brown
Journal:  Health Soc Care Community       Date:  2022-01-05

Review 3.  Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States.

Authors:  Elissa Meites; Timothy J Wilkin; Lauri E Markowitz
Journal:  Hum Vaccin Immunother       Date:  2022-03-16       Impact factor: 3.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.